Average Co-Inventor Count = 8.88
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novartis Ag (12 from 3,923 patents)
2. Exelixis, Inc. (2 from 175 patents)
14 patents:
1. 12157737 - Heteroaryl substituted spiropiperidinyl derivatives and pharmaceutical uses thereof
2. 12129246 - Hydroquinazoline derivatives for the treatment of a disease or disorder
3. 12084442 - Naphthyridinone derivatives for the treatment of a disease or disorder
4. 11708366 - Heteroaryl substituted spiropiperidinyl derivatives and pharmaceutical uses thereof
5. 11672799 - 1,4-disubstituted pyridazine quinolne analogs there of and methods for treating SMN-deficiency-related conditions
6. 11229648 - 1,4-disubstituted pyridazine analogs thereof and methods for treating SMN-deficiency-related conditions
7. 10758533 - 1,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions
8. 10195196 - 1,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions
9. 9545404 - 1,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions
10. 9227982 - 4-oxo-3,5,7,8-tetrahydro-4H-pyrano[4,3-d]pyrminidinyl compounds for use as tankyrase inhibitors
11. 9181266 - 2-piperidin-1-yl-acetamide compounds for use as tankyrase inhibitors
12. 8729263 - 1,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions
13. 8211929 - Pyrimidine derivatives as kinase modulators and method of use
14. 8013156 - Tie-2 modulators and methods of use